US patent will soak up the red ink at Peptech: Kwik
20 September, 2002 by David BinningAustralian biotech hopeful Peptech got the green light from the US patents office for its Tumour Necrosis Factor Antibodies technique this week.
Product rollout keeps VRI confident despite loss
20 September, 2002 by Pete YoungNatural health products company VRI Biomedical has reason to be upbeat about its future despite posting the largest annual loss in its short history.
Tax offset to hurt small biotechs
20 September, 2002 by Graeme O'NeillThe Federal government's 'Backing Australia's Ability' package seems to have backed right over small biotechnology companies, crushing their hopes for substantial cash rebates on their R&D expenditure.
CAREERS SPECIAL: Digging for talent
17 September, 2002 by Pete YoungAustralia's growing biotech industry has sparked recruitment sector interest. Pete Young surveys the scene
CAREER SPECIAL: Risk and reward
17 September, 2002 by Graeme O'NeillGraeme O'Neill reports on the hiring challenges faced by small-to-medium Australian biotechs
Nanotech expert to assist Chief Scientist
16 September, 2002 by Graeme O'NeillCSIRO nanotechnology expert Dr Vijoleta Braach-Maksvytis has been appointed to a new, part-time role as head of the Office of the Chief Scientist, to assist Chief Scientist Dr Robin Batterham.
Agencies freed from external funding obligations
16 September, 2002 by Pete YoungAustralia's premier science research agencies have been freed of the mandatory need to earn up to 30 percent of their government-supplied income from external sources.
McGauran hopes R&D Start scheme will return in 2003
12 September, 2002 by Melissa TrudingerThe return of the Federal government's R&D Start grant scheme may be on the horizon, according to Federal Minister for Science Peter McGauran.
Proctor & Gamble to trial Ambri's biosensor
11 September, 2002 by Melissa TrudingerSydney-based company Ambri has announced that it has entered into an agreement with US consumer products giant Proctor & Gamble.
Analytica rises from the ashes
10 September, 2002 by Pete YoungThe Lazarus-like revival of diagnostics company Analytica offers a ray of hope for young Australian biotechs caught in the current funding drought.
The other Big Australian
09 September, 2002 by Melissa TrudingerAs Australia's biggest public research institution, CSIRO occupies a unique niche. Employing 6500 people, the organisation has a huge diversity of scientific skills to apply to Australia's industries.
Synchrotron seeking commercial director
06 September, 2002 by Melissa TrudingerThe Australian Synchrotron Project has progressed to the stage where it requires a commercial director to develop commercial and policy frameworks.
Biocomm names Canadian as chief operating officer
04 September, 2002 by Iain ScottMelbourne-based life science commercialisation company Biocomm Services has appointed former Calgary Innovation Centre (CIC) executive director Lawrence Bremner as its new chief operating officer.
Former GroPep CEO Ballard launches angel fund
03 September, 2002 by Melissa TrudingerA new business angel network, BioAngels Inc, has been launched in Adelaide by former GroPep CEO John Ballard.
Name change for Sydney institute
03 September, 2002 by Melissa TrudingerThe Institute of Respiratory Medicine in Sydney has changed its name to the Woolcock Institute of Medical Research in honour of its founding director Prof Ann Woolcock AO.
